Evaluating neck treatment strategies for early oral cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of radiotherapy compared to elective neck dissection in patients with early oral cancer who have poor pathological factors. It is a randomized, prospective, multicenter study where participants will undergo primary tumor resection followed by either radiotherapy or selective neck dissection. The primary endpoint is the neck control rate over two years, while secondary endpoints include disease-free survival and overall survival at various intervals, as well as quality of life assessments. The study seeks to clarify treatment standards for early oral cancer and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Ability to understand and the willingness to sign a written informed consent document
2. Age≥ 18 and≤ 75 years
3. Clinical/ Histological/ cytological/ Imaging examination proven Oral/Oropharynx Squamous-cell carcinoma (Tongue, buccal mucosa, mouth floor, hard palate, Molar area), the depth of invasion \> 4mm in preoperative assessment
4. In line with clinical stage I / II stage (T1-2 N0 M0; AJCC 2010) and receiving surgical resection
5. KPS≥ 70
6. Normal bone marrow reserve function and normal liver, kidney function
7. Expected survival period≥ 6 months

Exclusion Criteria:

1. Inability to provide an informed consent
2. Evidence of oral distant metastasis or other malignancies
3. The patient has received prior surgery for primary tumor or lymph node ( except for biopsy )
4. Prior radiotherapy for primary tumor
5. The patient has previously received anti-tumor biological targeted therapy
6. The patient has received chemotherapy or immunotherapy for primary tumors
7. Prior malignancy within the previous 5 years (except for cured skin basal cell carcinoma or cervical carcinoma in situ)
8. With 3-4 grad Allergy to any drug in the treatment
9. Peripheral neuropathy\> 1 grade
10. Any unstable systematic disease (including active infection, uncontrolled high blood pressure, unstable angina, onset of angina within the last 3 months, congestive heart failure, myocardial infarction within the previous 12 months, severe arrhythmia needing drug treatment, liver, kidney or metabolic disease)
11. HIV positive
12. Chronic diseases requiring immune agents or hormone therapy
13. Pregnant or lactating women
14. Drug/alcohol abuse, psychological or spiritual illness that may interfere compliance to the study
15. Patients with epilepsy requiring medications (such as steroids or antiepileptic drugs)
16. The patient has participated in other experimental therapy studies within 30 days
17. Researchers believe that the situation is unsuitable for participation in the group

Where it's running

• Shanghai Ninth People's Hospital
  Shanghai, China Recruiting

Study contacts

• Principal investigator: Chenping ZHANG, Ph.D — Shanghai Ninth People's Hospital Shanghai, China, 200011
• Study coordinator: Chenping ZHANG, Ph.D
• Email: zhang.chenping@hotmail.com
• Phone: +86-21-63136856

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intratumoral fluorescent nivolumab before surgery in head and neck cancer

  This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.

  Recruiting Early Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07741565

• AI-assisted prehabilitation to help oral cancer patients return to work

  This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.

  Recruiting at 4 sites Taipei Veterans General Hospital, Taiwan · Taipei and 4 other locations · NCT07562100

• AI tool to measure jaw, neck, and shoulder movement for oral cancer care

  This project tests an AI system that automatically measures jaw, neck, and shoulder movement for people with or recovering from oral cancer and compares its readings to manual measurements.

  Recruiting National Taiwan University Hospital · Taipei · NCT07509619

• Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction

  This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07401641

• Hydrogen water oral care after free flap reconstruction for oral cancer

  A randomized trial tests whether hydrogen water oral care helps reduce inflammation and pain and improve oral bacteria after surgery for oral cancer.

  Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City · NCT07306546

• Monitoring circulating tumor cells in postoperative ENE-positive oral cavity cancer after adjuvant concurrent chemoradiation.

  This trial will test whether regular blood monitoring of circulating tumor cells and adding extended low-dose oral chemotherapy can help people with ENE-positive oral cavity squamous cell carcinoma after surgery and adjuvant concurrent chemoradiation.

  Recruiting Chang Gung Memorial Hospital · Taoyuan City · NCT07296250

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.